1. Levin, SR, Arinze, N, Siracuse, JJ. Lower extremity critical limb ischemia: a review of clinical features and management. Trends Cardiovasc Med 2020; 30(3): 125–130.
Google Scholar | Crossref | Medline2. Farber, A, Eberhardt, RT. The current state of critical limb ischemia. JAMA Surg 2016; 151(11): 1070.
Google Scholar | Crossref | Medline3. Higashi, Y, Miyata, T, Shigematsu, H, et al. evaluation of risk factors for major amputation in patients with diabetes and peripheral artery disease receiving antiplatelet therapy ― post hoc analysis of a prospective observational multicenter cohort study (SEASON) ―. Circ J 2019; 83(9): 1929–1936.
Google Scholar | Crossref | Medline4. Duff, S, Mafilios, MS, Bhounsule, P, et al. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag 2019; 15: 187–208.
Google Scholar | Crossref | Medline5. Roijers, JJP, Rakké, BYS, Hopmans, NCJ, et al. Adverse cardiac events and mortality in patients with critical limb ischemia. Ann Vasc Surg 2020; 66: 486–492.
Google Scholar | Crossref | Medline6. Newton, DH, Kim, C, Lee, N, et al. Sarcopenia predicts poor long-term survival in patients undergoing endovascular aortic aneurysm repair. J Vasc Surg 2018; 67(2): 453–459.
Google Scholar | Crossref | Medline7. Sivaharan, A, Boylan, L, Witham, MD, et al. Sarcopenia in patients undergoing lower limb bypass surgery is associated with higher mortality and major amputation rates. Ann Vasc Surg 2021; 75: P227–P236.
Google Scholar | Crossref | Medline8. Matsubara, Y, Matsumoto, T, Aoyagi, Y, et al. Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg 2015; 61(4): 945–950.
Google Scholar | Crossref | Medline9. Cruz-Jentoft, AJ, Bahat, G, Bauer, J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing 2019; 48(1): 16–31.
Google Scholar | Crossref | Medline10. Marzetti, E, Calvani, R, Calvani, R, et al. Sarcopenia: an overview. Aging Clin Exp Res 2017; 29(1): 11–17.
Google Scholar | Crossref | Medline11. Pizzimenti, M, Charles, AL, Riou, M, et al. Usefulness of platelet-to-lymphocyte ratio as a marker of sarcopenia for critical limb threatening ischemia. Ann Vasc Surg 2021; 72: 72–78.
Google Scholar | Crossref | Medline12. Stoner, MC, Calligaro, KD, Chaer, RA, et al. Reporting standards of the society for vascular surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg 2016; 64(1): e1–e21.
Google Scholar | Crossref | Medline | ISI13. Khwaja, A . KDIGO clinical practice guidelines for acute kidney injury. Nephron 2012; 120(4): c179–c184.
Google Scholar | Crossref | Medline14. Parvar, SL, Fitridge, R, Dawson, J, et al. Medical and lifestyle management of peripheral arterial disease. J Vasc Surg 2018; 68(5): 1595–1606.
Google Scholar | Crossref | Medline15. Addison, O, Prior, SJ, Kundi, R, et al.. Sarcopenia in peripheral arterial disease: prevalence and effect on functional status. Arch Phys Med Rehabil 2018; 99(4): 623–628.
Google Scholar | Crossref | Medline16. Pizzimenti, M, Meyer, A, Charles, AL, et al.. Sarcopenia and peripheral arterial disease: a systematic review. J Cachexia, Sarcopenia Muscle 2020; 11(4): 866–886.
Google Scholar | Crossref | Medline17. Rubio-Ruiz, M, Guarner-Lans, V, Pérez-Torres, I, et al. Mechanisms underlying metabolic syndrome-related sarcopenia and possible therapeutic measures. Int J Mol Sci 2019; 20(3): 647.
Google Scholar | Crossref18. McDermott, MM, Liu, K, Tian, L, et al. Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease. J Am Coll Cardiol 2012; 59(13): 1159–1167.
Google Scholar | Crossref | Medline | ISI19. Reeve, TE, Ur, R, Craven, TE, et al. Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia. J Vasc Surg 2018; 67(5): 1512–1520.
Google Scholar | Crossref | Medline20. Taniguchi, R, Deguchi, J, Hashimoto, T, et al. Sarcopenia as a possible negative predictor of limb salvage in patients with chronic limb-threatening ischemia. Ann Vasc Dis 2019; 12(2): 194–199.
Google Scholar | Crossref | Medline21. Matsubara, Y, Matsumoto, T, Inoue, K, et al. Sarcopenia is a risk factor for cardiovascular events experienced by patients with critical limb ischemia. J Vasc Surg 2017; 65(5): 1390–1397.
Google Scholar | Crossref | Medline22. Shimazoe, H, Mii, S, Koyanagi, Y, et al. Impact of low activity of daily living on the prognosis of patients with critical limb ischemia and sarcopenia. Ann Vasc Surg 2019; 61: 156–164.
Google Scholar | Crossref | Medline23. Studenski, SA, Peters, KW, Alley, DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. The Journals Gerontol Ser A 2014; 69(5): 547–558.
Google Scholar | Crossref | Medline24. Fielding, RA, Vellas, B, Evans, WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Directors Assoc 2011; 12(4): 249–256.
Google Scholar | Crossref | Medline | ISI25. Heard, R, Black, D, Ramsay, G, et al. The prevalence of sarcopaenia in a vascular surgical patient cohort and its impact on outcome. The Surgeon 2018; 16(6): 325–332.
Google Scholar | Crossref | Medline26. Waduud, MA, Wood, B, Keleabetswe, P, et al. Influence of psoas muscle area on mortality following elective abdominal aortic aneurysm repair. Br J Surg 2019; 106(4): 367–374.
Google Scholar | Crossref | Medline27. Marzetti, E, Calvani, R, Cesari, M, et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cel Biol 2013; 45(10): 2288–2301.
Google Scholar | Crossref | Medline | ISI28. Liaw, F-Y, Huang, C-F, Chen, W-L, et al. Higher platelet-to-lymphocyte ratio increased the risk of sarcopenia in the community-dwelling older adults. Scientific Rep 2017; 7(1): 16609.
Google Scholar | Crossref | Medline29. Zhao, W-Y, Zhang, Y, Hou, L-S, et al. The association between systemic inflammatory markers and sarcopenia: results from the West China health and aging trend study (WCHAT). Arch Gerontol Geriatr 2021; 92: 104262.
Google Scholar | Crossref | Medline30. Gary, T, Pichler, M, Belaj, K, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. Plos One 2013; 8(7): e67688. Kirchmair R (ed).
Google Scholar | Crossref | Medline | ISI31. Erdoğan, SB, Selçuk, ÜN, Baştopçu, M, et al. Critical limb ischemia patients clinically improving with medical treatment have lower neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios. Vascular 2021; 29: 920–926.
Google Scholar | SAGE Journals32. Ye, M, Qian, X, Guo, X, et al. Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans. Ann Vasc Surg 2020; 64: 221–227.
Google Scholar | Crossref | Medline33. Huang, H-L, Juang, J-MJ, Hsieh, C-A, et al. Risk stratification for low extremity amputation in critical limb ischemia patients who have undergone endovascular revascularization. Medicine 2019; 98(33): e16809.
Google Scholar | Crossref | Medline